These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2040181)

  • 21. 2,3 diphosphoglycerate-haemoglobin binding in uraemic patients treated with erythropoietin. A 31P-nuclear magnetic resonance study.
    Monti JP; Brunet P; Baz M; Klinkmann H; Berland Y; Merzouk T; Elsen R; Crevat A
    Nephrol Dial Transplant; 1993; 8(3):223-6. PubMed ID: 8385288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
    Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
    Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
    Laupacis A
    Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA
    Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
    Harris SA; Payne G; Putman JM
    Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1988 Oct; 118(40):1423-6. PubMed ID: 3187475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 29. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of renal anemia].
    Koch KM
    Verh Dtsch Ges Inn Med; 1989; 95():246-8. PubMed ID: 2603482
    [No Abstract]   [Full Text] [Related]  

  • 32. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.
    Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D
    Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anemia: a clinical report.
    von Bormann B; Weiler J; Aulich S
    Clin Investig; 1994; 72(6 Suppl):S31-5. PubMed ID: 7950170
    [No Abstract]   [Full Text] [Related]  

  • 35. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
    Birgegård G; Gudbjrönsson B; Hällgren R; Wide L
    Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 37. Quiz of the month.
    Norris SH
    Am J Nephrol; 1990; 10(5):412, 433-5. PubMed ID: 2080793
    [No Abstract]   [Full Text] [Related]  

  • 38. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
    Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
    Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect erythropoietin-beta on parameters of erythropoiesis and immunity in patients with diabetes mellitus complicated with diabetic neuropathy and anemia].
    Ivanchenko OV; Zak KP; Gruzov MA; Kulikovskaia AV; Efimov AS
    Lik Sprava; 2004; (7):84-7. PubMed ID: 15724624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of uraemic anaemia with recombinant human erythropoietin.
    Ponticelli C; Casati S; Campise M
    Adv Exp Med Biol; 1989; 260():53-9. PubMed ID: 2696371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.